Tag: Rheumatoid Arthritis

T2T approach in women with RA associated with increased fertility

Presented By
Prof. Radboud Dolhain, Erasmus University Medical Center, the Netherlands
Conference
ACR 2024
Type
Peer-reviewed article

13 January 2025 12:06

Positive results for vagus nerve stimulation in RA

Presented By
Dr John Tesser, Arizona Arthritis & Rheumatology Associates, AZ, USA
Trial
Phase 3, RESET-RA
Conference
ACR 2024
Type
Peer-reviewed article

13 January 2025 12:05

Machine learning to aid evaluation of ANA pattern and titer

Presented By
Dr May Choi, University of Calgary, Canada
Conference
ACR 2024
Type
Peer-reviewed article

13 January 2025 12:04

Registry participation can enhance quality of rheumatology care

Presented By
Dr Gabriela Schmajuk, University of California, San Francisco, CA, USA
Conference
ACR 2024
Type
Peer-reviewed article

13 January 2025 11:07

New JAK1 inhibitor outperforms placebo in active RA

Presented By
Dr Jinjing Liu, Peking Union Medical College Hospital, China
Trial
Phase 3
Conference
EULAR 2024
Type
Peer-reviewed article

29 July 2024 14:37

Macrophage profiling in synovial tissue predicts treatment response in RA

Presented By
Dr Simone Perniola, Policlinico Universitario A. Gemelli IRCS, Italy
Conference
EULAR 2024
Type
Peer-reviewed article

29 July 2024 14:36

Innovative app boosts mental health in patients with RA

Presented By
Prof. Frank Behrens, Goethe-University & Fraunhofer ITMP, Germany
Conference
EULAR 2024
Type
Peer-reviewed article

29 July 2024 14:35

Stopping DMARDs? These key factors predict RA flares

Presented By
Dr Fiona Rayner, Newcastle University, UK
Trial
BIO-FLARE
Conference
EULAR 2024
Type
Peer-reviewed article

29 July 2024 14:27

Improving outcomes in pregnancy and psoriatic disease

Presented By
Dr Oseme Etomi, Guy's and St Thomas' Hospital, UK
Conference
IFPA 2024
Type
News article

17 July 2024 13:44

Interview: Medicare’s first drug price negotiations: concerning?

Expert
Prof. Marc Bonaca, University of Colorado, USA

4 January 2024 15:06

Short-term glucocorticoid use increases the risk of MACE

Presented By
Dr Beth Wallace, University of Michigan, MI, USA
Conference
ACR 2023
Type
News article

1 December 2023 12:32

Baricitinib superior to TNFi in patients with RA who failed csDMARDs

Presented By
Dr Mart van der Laar, University of Twente, The Netherlands
Trial
PerfectRA
Conference
ACR 2023
Type
News article

1 December 2023 11:40

Therapy with biological DMARDs shows no correlation with fracture risk in RA

Presented By
Ms Ingebjorg Tronstad, Norwegian University of Science and Technology, Norway
Trial
HUNT
Conference
EULAR 2023
Type
Peer-reviewed article

31 July 2023 06:50

Poly-refractory RA: not common, but still present

Presented By
Dr Paula David, University of Leeds, UK
Conference
EULAR 2023
Type
Peer-reviewed article

31 July 2023 06:04

COBRA-Slim bio-induction: no benefit compared with the standard regimen

Trial
CareRA2020
Conference
EULAR 2023
Type
Peer-reviewed article

31 July 2023 05:59

AI almost as successful as experts in predicting early RA

Presented By
Dr Yanli Li, Leiden University Center, the Netherlands
Conference
EULAR 2023
Type
Peer-reviewed article

31 July 2023 05:54

Disease activity-guided dose reduction may be a long-term option for stable RA

Presented By
Dr Noortje van Herwaarden, Sint Maartenskliniek, the Netherlands
Trial
DRESS
Conference
EULAR 2023
Type
Peer-reviewed article

31 July 2023 05:40

Cardiovascular safety of JAK inhibitors: reassuring results from a real-world study

Presented By
Mr Romain Aymon, Geneva University Hospital, Switzerland
Trial
ORAL Surveillance
Conference
EULAR 2023
Type
Peer-reviewed article

31 July 2023 00:00

Selective JAK1/TYK 2 inhibitor effective in patients with difficult-to-treat RA

Presented By
Prof. Xiaofeng Zeng, Peking Union Medical College Hospital, China
Conference
EULAR 2023
Type
Peer-reviewed article

30 July 2023 23:53

Stimulation of PD-1: a new concept to treat RA

Presented By
Prof. Paul Emery, University of Leeds, UK
Trial
Phase 2
Conference
ACR 2022
Type
News article

1 December 2022 14:28

High retention rates after switching between infliximab biosimilars

Presented By
Dr Hafsah Nabi, Rigshospitalet, Denmar
Conference
ACR 2022
Type
News article

1 December 2022 14:21

New analysis assesses the safety of tofacitinib regarding extended MACE

Presented By
Prof. Maya Buch, University of Manchester, United Kingdom
Trial
ORAL Surveillance
Conference
ACR 2022
Type
News article

1 December 2022 14:18

Lack of vaccination results in a higher frequency of pre-term births in pregnant women with rheumatic disease and COVID-19

Presented By
Dr Sinead Magui, St. James’ Hospital, Ireland
Conference
ACR 2022
Type
News article

1 December 2022 14:12

Early treatment: a key to improved outcomes in polyarticular JIA

Presented By
Prof. Yukiko Kimura, Hackensack Meridian School of Medicine, USA
Trial
STOP-JIA
Conference
ACR 2022
Type
News article

1 December 2022 12:23

No increased cancer risk in patients with rheumatic diseases and prior malignancy treated with novel therapies

Presented By
Dr Juan Molina Collada , Gregorio Marañón General University Hospital, Spain
Trial
BIOBADASER
Conference
ACR 2022
Type
News article

1 December 2022 12:03

Antifibrotic therapy may slow down FVC decline in RAILD 

Presented By
Prof. Ivan Rosas, Baylor College of Medicine, TX, USA
Trial
Phase 2, TRAIL1
Conference
ERS 2022
Type
Peer-reviewed article

30 October 2022 22:11

Alarmingly low activity in patients with non-inflammatory and inflammatory rheumatic disease

Presented By
Prof. Luca Quartuccio, University of Udine, Italy
Conference
EULAR 2022
Type
Peer-reviewed article

21 July 2022 19:31

Many RA and PsA patients have problems with their sex life

Presented By
Dr Carlos Valera-Ribera , Doctor Peset University Hospital, Spain
Conference
EULAR 2022
Type
Peer-reviewed article

21 July 2022 17:12

Comorbid depression comes with a profoundly higher mortality risk in RA

Presented By
Dr Jens Kristian Pedersen, Odense University Hospital, Denmark
Conference
EULAR 2022
Type
Peer-reviewed article

21 July 2022 15:10

Preventive treatment with methotrexate benefits pre-RA patients with arthralgia

Presented By
Dr Doortje Krijbolder, Leiden University Medical Center, the Netherlands
Trial
TREAT EARLIER
Conference
EULAR 2022
Type
Peer-reviewed article

21 July 2022 15:07

Risk factors for dementia in RA patients discovered

Presented By
Prof. Elena Myasoedova , Mayo Clinic, MN, USA
Conference
EULAR 2022
Type
Peer-reviewed article

21 July 2022 15:02

VTE in global registry data more common in JAK inhibitor-treated RA patients

Presented By
Prof. Adeline Ruyssen-Witrand, Toulouse University Hospital, France
Conference
EULAR 2022
Type
Peer-reviewed article

21 July 2022 14:52

JAK inhibitors: A risk assessment

Presented By
Prof. Brett King, Yale School of Medicine, USA
Conference
AAD 2022
Type
Peer-reviewed article

17 May 2022 10:59

Patients on immunomodulators need 2 COVID-19 vaccinations before seroconversion

Presented By
Dr Ali Al-Janabi, University of Manchester, UK
Conference
PFGC 2021
Type
Peer-reviewed article

2 February 2022 15:22

Cycling JAK inhibitors shows similar effectiveness to switching to a bDMARD in difficult-to-treat RA

Presented By
Dr Manuel Pombo-Suarez, Hospital Clinico Universitario de Santiago De Compostela, Spain
Trial
JAK-pot
Conference
ACR 2021
Type
Peer-reviewed article

14 January 2022 11:03

Pre-existing heart failure affects safety of hydroxychloroquine in RA patients

Presented By
Dr Elvira D’Andrea, Brigham and Women’s Hospital, MA, USA
Conference
ACR 2021
Type
Peer-reviewed article

14 January 2022 11:01

Patients with RA-associated interstitial lung disease benefit from antifibrotic agent

Presented By
Prof. Joshua J. Solomon, National Jewish Health, CO, USA
Trial
Phase 2, TRAIL1
Conference
ACR 2021
Type
Peer-reviewed article

14 January 2022 10:59

Ultra-low dosing of rituximab in RA is a viable treatment option

Presented By
Mr Nathan den Broeder, Sint Maartenskliniek, the Netherlands
Trial
REDO
Conference
ACR 2021
Type
Peer-reviewed article

14 January 2022 10:58

Kidney disease and hydroxychloroquine dose are risk factors for developing retinopathy

Presented By
Dr April Jorge, Massachusetts General Hospital, MA, USA
Conference
ACR 2021
Type
Peer-reviewed article

14 January 2022 10:55

More pros than cons for the use of statins in RA

Presented By
Dr Gulsen Ozen, University of Nebraska Medical Center, NE, USA
Conference
ACR 2021
Type
Peer-reviewed article

14 January 2022 10:54

Vaccinated rheumatic patients carry increased risk for COVID-19 breakthrough infections

Presented By
Prof. Jasvinder Singh, University of Alabama at Birmingham, AL, USA
Conference
ACR 2021
Type
Peer-reviewed article

14 January 2022 10:47

B-cell depleting medication increases COVID-19 breakthrough infection outcome risk

Presented By
Prof. Jean Liew, Boston University, MA, USA
Conference
ACR 2021
Type
Peer-reviewed article

14 January 2022 10:45

COVID-19 mRNA vaccine safe and tolerable in adults with autoimmune disease

Presented By
Dr Inés Colmegna, McGill University Health Centre, Canada
Conference
ACR 2021
Type
Peer-reviewed article

14 January 2022 10:06

ACR 2021 Highlights Podcast

Presented By
Dr Rachel Giles, Medicom
Conference
ACR 2021

22 November 2021 16:18

Remote management of RA is a feasible alternative for outpatient follow-up

Presented By
Dr Mwidimi Ndosi, University of the West of England, UK
Conference
EULAR 2021
Type
Peer-reviewed article

2 August 2021 22:57

Fenebrutinib at highest dose generally well tolerated

Conference
AAN 2021
Type
Peer-reviewed article

16 June 2021 11:49

Rheumatoid arthritis and interstitial lung disease: a deadly combination

Presented By
Prof. Joan Bathon, Columbia University, USA
Conference
ACR 2020
Type
Peer-reviewed article

18 January 2021 10:59

Preliminary findings suggest rozibafusp alfa effective and tolerable in RA

Conference
EULAR 2020
Type
Peer-reviewed article

14 August 2020 09:56

Immune-related AEs due to checkpoint inhibitors require care coordination

Conference
EULAR 2020
Type
Peer-reviewed article

14 August 2020 09:49

New nanoparticle promising future agent in RA

Presented By
Prof. Kira Astakhova, Technical University of Denmark, Denmark
Conference
EULAR 2020
Type
Peer-reviewed article

14 August 2020 09:43

Olokizumab significantly improves RA features and patient-reported outcomes

Presented By
Prof. Rumen Stoilov, University Hospital St. Ivan Rilski, Bulgaria
Trial
CREDO-1
Conference
EULAR 2020
Type
Peer-reviewed article

14 August 2020 09:33

Low DAS at 4 months predicts sustained DMARD-free remission

Presented By
Ms Marloes Verstappen, Leiden University Medical Center, the Netherlands
Conference
EULAR 2020
Type
Peer-reviewed article

14 August 2020 07:50

Few serious infections in offspring with exposure to non-TNFi biologics or tofacitinib

Presented By
Dr Evelyne Vinet, McGill University, Montreal, Canada
Conference
ACR 2019
Type
Peer-reviewed article

4 February 2020 23:12

Filgotinib promising in RA patients naïve to methotrexate

Presented By
Prof. Rene Westhovens, University of Leuven, Belgium
Trial
Phase 3, FINCH 3
Conference
ACR 2019
Type
Peer-reviewed article

4 February 2020 23:05

Sustained efficacy of monotherapy with upadacitinib after 48 weeks

Presented By
Prof. Joseph Smolen, Medical University of Vienna, Austria
Trial
SELECT-MONOTHERAPY
Conference
ACR 2019
Type
Peer-reviewed article

4 February 2020 22:06

Proteome abnormalities improve prediction of RA development

Presented By
Dr Liam O´Neil, University of Manitoba, Canada
Conference
ACR 2019
Type
Peer-reviewed article

4 February 2020 21:47

Biologics show similar activity in patients with elderly-onset RA

Presented By
Dr Sadao Jinno, Kobe University School of Medicine, Japan
Conference
ACR 2019
Type
Peer-reviewed article

4 February 2020 21:08

RA patients in remission benefit from continued therapy with conventional DMARDs

Presented By
Dr Siri Lillegraven, Diakonhjemmet Hospital,Norway
Trial
ARCTIC REWIND, TARA
Conference
ACR 2019
Type
Peer-reviewed article

4 February 2020 20:51

Tocilizumab outperforms rituximab in RA patients with low level of synovial B cell infiltration

Presented By
Prof. Costantino Pitzalis, Barts and The London School of Medicine and Dentistry, UK
Conference
ACR 2019
Type
Peer-reviewed article

4 February 2020 20:10

Treatment decisions should not be guided by ultrasound findings

Presented By
Dr Espen Haavardsholm, Diakonhjemmet Hospital, Oslo, Norway
Trial
ARCTIC, TaSER
Conference
ACR 2019
Type
Peer-reviewed article

4 February 2020 19:11

Cancer treatment with checkpoint inhibitors in RA patients?

Presented By
Dr Sabina Sandigursky, New York University Langone Medical Center, USA
Conference
ACR 2019
Type
Peer-reviewed article

4 February 2020 11:13

TNFi for RA during pregnancy – to stop or not to stop?

Presented By
Dr Isabell Haase, Heinrich-Heine University Düsseldorf, Germany
Conference
ACR 2019
Type
Peer-reviewed article

4 February 2020 10:16

Cohort study shows improvement during 25 years of RA treatment

Presented By
Dr Xanthe Matthijssen, Leiden University Medical Center, the Netherlands
Conference
EULAR 2019
Type
Peer-reviewed article

4 September 2019 23:13

Filgotinib in RA patients with inadequate response or naïve to methotrexate

Presented By
Prof. Rene Westhovens, University Hospital Leuven, Belgium
Trial
Phase 3, FINCH-3
Conference
EULAR 2019
Type
Peer-reviewed article

4 September 2019 22:35

Clinical effectiveness of fenebrutinib in RA patients with methotrexate or TNFi failure

Presented By
Dr Stanley Cohen, Metroplex Clinical Research Center, Dallas, USA
Conference
EULAR 2019
Type
Peer-reviewed article

4 September 2019 21:38

Peficitinib likely efficacious and safe

Conference
EULAR 2019
Type
Peer-reviewed article

4 September 2019 20:42

Short methotrexate stop is safe in patients with RA

Presented By
Dr Min Jung Kim, Seoul National University Hospital, South Korea
Conference
EULAR 2019
Type
Peer-reviewed article

4 September 2019 19:47

Tofacitinib is safe according to real-world data analysis

Presented By
Dr Joel Kremer, Albany Medical College, New York, USA
Conference
EULAR 2019
Type
Peer-reviewed article

4 September 2019 18:51

Switching upadacitinib and adalimumab is beneficial in refractory RA

Trial
Phase 3, SELECT-COMPARE
Conference
EULAR 2019
Type
Peer-reviewed article

4 September 2019 17:54

Tapering of prednisone in RA patients who achieved low disease activity or remission with tocilizumab

Presented By
Prof. Gerd Burmester, Free University and Humboldt University of Berlin, Germany
Conference
EULAR 2019
Type
Peer-reviewed article

4 September 2019 16:56

Efficacy and safety of E6011 in RA patients with inadequate response to methotrexate

Presented By
Dr Yoshiya Tanaka, University of Occupational and Environmental Health, Japan
Conference
EULAR 2019
Type
Peer-reviewed article

4 September 2019 15:58

Preliminary efficacy and safety data of RG6125 in RA patients with an inadequate response to TNF inhibitors

Presented By
Uwe Junker, Roche Innovation Center Basel, Switzerland
Conference
EULAR 2019
Type
Peer-reviewed article

4 September 2019 14:01

Integrated 10-year analysis confirms safety profile abatacept

Presented By
Dr Teresa Simon, Bristol-Myers Squibb, USA
Trial
Cohort study, ARTIS, RABBIT, FORWARD, British Columbia Canadian RA Cohort
Conference
EULAR 2019
Type
Peer-reviewed article

4 September 2019 13:03

Switching among multiple infliximab biosimilars does not cause immunogenicity

Presented By
Dr Jéróme Avouac, Paris Descartes University, France
Conference
EULAR 2019
Type
Peer-reviewed article

4 September 2019 12:06

NSAIDs consumption is linked to patient-assessed disease activity and decreases with use of TNF inhibitors

Presented By
Dr Olafur Palsson, University Hospital Reykjavik, Iceland
Trial
ICEBIO database
Conference
EULAR 2019
Type
Peer-reviewed article

4 September 2019 10:11

IBD risk of treatment with IL-17 antagonists

Presented By
Dr Wolfgang Eigner, Medical University of Vienna, Austria
Conference
ECCO 2019
Type
Peer-reviewed article

9 May 2019 14:37

Psoriasis and Biologics: The Beat Goes On

Presented By
Prof. Mark Lebwohl, Mount Sinai School of Medicine, USA
Conference
AAD 2019
Type
Peer-reviewed article

19 April 2019 14:06

Biologic drug levels and infection risk, and clinical effectiveness of sarilumab

Trial
TARGET
Conference
EULAR 2018
Type
Peer-reviewed article

24 August 2018 19:30

Confirmation of long-term safety profile adalimumab across indications

Presented By
Prof. Gerd Burmester, Charité University Hospital, Free University and Humboldt University of Berlin, Germany
Conference
EULAR 2018
Type
Peer-reviewed article

24 August 2018 18:39
site created by:   

© 2024 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy



HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com